Chronic natural killer-cell lymphocytosis successfully treated with alemtuzumab

Blood. 2009 Oct 15;114(16):3500-2. doi: 10.1182/blood-2009-07-233403.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Alemtuzumab
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm / administration & dosage*
  • Antineoplastic Agents / administration & dosage*
  • Chronic Disease
  • Humans
  • Killer Cells, Natural*
  • Livedo Reticularis / blood
  • Livedo Reticularis / diagnosis
  • Livedo Reticularis / drug therapy
  • Livedo Reticularis / pathology
  • Lymphocytosis / blood
  • Lymphocytosis / diagnosis
  • Lymphocytosis / drug therapy*
  • Lymphocytosis / pathology
  • Male
  • Polyarteritis Nodosa / blood
  • Polyarteritis Nodosa / diagnosis
  • Polyarteritis Nodosa / drug therapy
  • Polyarteritis Nodosa / pathology
  • Remission Induction

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Antineoplastic Agents
  • Alemtuzumab